Sign up to save your podcasts
Or
Share Primary Care Update Episode 13
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Primary Care Update Episode 13
Today we talk about the impact of more primary care physicians in a population on health outcomes; whether or not probiotics, prebiotics, and antibiotics are helpful for irritable bowel; and the impact of SGLT-2 inhibitors like empagliflozin on cardiovascular outcomes in diabetics with heart disease or at very high risk.
View all episodes
By Mark Ebell
4.7
9292 ratings
Today we talk about the impact of more primary care physicians in a population on health outcomes; whether or not probiotics, prebiotics, and antibiotics are helpful for irritable bowel; and the impact of SGLT-2 inhibitors like empagliflozin on cardiovascular outcomes in diabetics with heart disease or at very high risk.
More shows like Primary Care Update
View all
JAMA Editors' Summary
134 Listeners
NEJM This Week
316 Listeners
JAMA Clinical Reviews
498 Listeners
AFP: American Family Physician Podcast
687 Listeners
Mayo Clinic Talks
280 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,326 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,105 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Run the List
252 Listeners
The Curious Clinicians
368 Listeners
The Cribsiders
313 Listeners